Global Gabapentin Market Insight and Forecast to 2026
The research team projects that the Gabapentin market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Pfizer
Sun Pharmaceutical
Mylan
Assertio Therapeutics
Apotex
TEVA
Intas
Novartis
Arbor Pharma
Aurobindo Pharma
Jiangsu Enhua
Amneal
Jiangsu Hengrui
Alkem
Marksans Pharma
Sailike
Glenmark
By Type
Capsule
Tablet
By Application
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Gabapentin 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Gabapentin Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Gabapentin Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gabapentin market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Pfizer
Sun Pharmaceutical
Mylan
Assertio Therapeutics
Apotex
TEVA
Intas
Novartis
Arbor Pharma
Aurobindo Pharma
Jiangsu Enhua
Amneal
Jiangsu Hengrui
Alkem
Marksans Pharma
Sailike
Glenmark
By Type
Capsule
Tablet
By Application
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Gabapentin 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Gabapentin Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Gabapentin Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gabapentin market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gabapentin Revenue
1.4 Market Analysis by Type
1.4.1 Global Gabapentin Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Capsule
1.4.3 Tablet
1.5 Market by Application
1.5.1 Global Gabapentin Market Share by Application: 2021-2026
1.5.2 Epilepsy
1.5.3 Neuropathic Pain
1.5.4 Restless Legs Syndrome
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gabapentin Market Perspective (2021-2026)
2.2 Gabapentin Growth Trends by Regions
2.2.1 Gabapentin Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Gabapentin Historic Market Size by Regions (2015-2020)
2.2.3 Gabapentin Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Gabapentin Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Gabapentin Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Gabapentin Average Price by Manufacturers (2015-2020)
4 GABAPENTIN PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Gabapentin Market Size (2015-2026)
4.1.2 Gabapentin Key Players in North America (2015-2020)
4.1.3 North America Gabapentin Market Size by Type (2015-2020)
4.1.4 North America Gabapentin Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Gabapentin Market Size (2015-2026)
4.2.2 Gabapentin Key Players in East Asia (2015-2020)
4.2.3 East Asia Gabapentin Market Size by Type (2015-2020)
4.2.4 East Asia Gabapentin Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Gabapentin Market Size (2015-2026)
4.3.2 Gabapentin Key Players in Europe (2015-2020)
4.3.3 Europe Gabapentin Market Size by Type (2015-2020)
4.3.4 Europe Gabapentin Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Gabapentin Market Size (2015-2026)
4.4.2 Gabapentin Key Players in South Asia (2015-2020)
4.4.3 South Asia Gabapentin Market Size by Type (2015-2020)
4.4.4 South Asia Gabapentin Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Gabapentin Market Size (2015-2026)
4.5.2 Gabapentin Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Gabapentin Market Size by Type (2015-2020)
4.5.4 Southeast Asia Gabapentin Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Gabapentin Market Size (2015-2026)
4.6.2 Gabapentin Key Players in Middle East (2015-2020)
4.6.3 Middle East Gabapentin Market Size by Type (2015-2020)
4.6.4 Middle East Gabapentin Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Gabapentin Market Size (2015-2026)
4.7.2 Gabapentin Key Players in Africa (2015-2020)
4.7.3 Africa Gabapentin Market Size by Type (2015-2020)
4.7.4 Africa Gabapentin Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Gabapentin Market Size (2015-2026)
4.8.2 Gabapentin Key Players in Oceania (2015-2020)
4.8.3 Oceania Gabapentin Market Size by Type (2015-2020)
4.8.4 Oceania Gabapentin Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Gabapentin Market Size (2015-2026)
4.9.2 Gabapentin Key Players in South America (2015-2020)
4.9.3 South America Gabapentin Market Size by Type (2015-2020)
4.9.4 South America Gabapentin Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Gabapentin Market Size (2015-2026)
4.10.2 Gabapentin Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Gabapentin Market Size by Type (2015-2020)
4.10.4 Rest of the World Gabapentin Market Size by Application (2015-2020)
5 GABAPENTIN CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Gabapentin Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Gabapentin Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Gabapentin Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Gabapentin Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Gabapentin Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Gabapentin Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Gabapentin Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Gabapentin Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Gabapentin Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Gabapentin Consumption by Countries
5.10.2 Kazakhstan
6 GABAPENTIN SALES MARKET BY TYPE (2015-2026)
6.1 Global Gabapentin Historic Market Size by Type (2015-2020)
6.2 Global Gabapentin Forecasted Market Size by Type (2021-2026)
7 GABAPENTIN CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Gabapentin Historic Market Size by Application (2015-2020)
7.2 Global Gabapentin Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN GABAPENTIN BUSINESS
8.1 Pfizer
8.1.1 Pfizer Company Profile
8.1.2 Pfizer Gabapentin Product Specification
8.1.3 Pfizer Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Sun Pharmaceutical
8.2.1 Sun Pharmaceutical Company Profile
8.2.2 Sun Pharmaceutical Gabapentin Product Specification
8.2.3 Sun Pharmaceutical Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Mylan
8.3.1 Mylan Company Profile
8.3.2 Mylan Gabapentin Product Specification
8.3.3 Mylan Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Assertio Therapeutics
8.4.1 Assertio Therapeutics Company Profile
8.4.2 Assertio Therapeutics Gabapentin Product Specification
8.4.3 Assertio Therapeutics Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Apotex
8.5.1 Apotex Company Profile
8.5.2 Apotex Gabapentin Product Specification
8.5.3 Apotex Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 TEVA
8.6.1 TEVA Company Profile
8.6.2 TEVA Gabapentin Product Specification
8.6.3 TEVA Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Intas
8.7.1 Intas Company Profile
8.7.2 Intas Gabapentin Product Specification
8.7.3 Intas Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Novartis
8.8.1 Novartis Company Profile
8.8.2 Novartis Gabapentin Product Specification
8.8.3 Novartis Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Arbor Pharma
8.9.1 Arbor Pharma Company Profile
8.9.2 Arbor Pharma Gabapentin Product Specification
8.9.3 Arbor Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Aurobindo Pharma
8.10.1 Aurobindo Pharma Company Profile
8.10.2 Aurobindo Pharma Gabapentin Product Specification
8.10.3 Aurobindo Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Jiangsu Enhua
8.11.1 Jiangsu Enhua Company Profile
8.11.2 Jiangsu Enhua Gabapentin Product Specification
8.11.3 Jiangsu Enhua Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Amneal
8.12.1 Amneal Company Profile
8.12.2 Amneal Gabapentin Product Specification
8.12.3 Amneal Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Jiangsu Hengrui
8.13.1 Jiangsu Hengrui Company Profile
8.13.2 Jiangsu Hengrui Gabapentin Product Specification
8.13.3 Jiangsu Hengrui Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Alkem
8.14.1 Alkem Company Profile
8.14.2 Alkem Gabapentin Product Specification
8.14.3 Alkem Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 Marksans Pharma
8.15.1 Marksans Pharma Company Profile
8.15.2 Marksans Pharma Gabapentin Product Specification
8.15.3 Marksans Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.16 Sailike
8.16.1 Sailike Company Profile
8.16.2 Sailike Gabapentin Product Specification
8.16.3 Sailike Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.17 Glenmark
8.17.1 Glenmark Company Profile
8.17.2 Glenmark Gabapentin Product Specification
8.17.3 Glenmark Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Gabapentin (2021-2026)
9.2 Global Forecasted Revenue of Gabapentin (2021-2026)
9.3 Global Forecasted Price of Gabapentin (2015-2026)
9.4 Global Forecasted Production of Gabapentin by Region (2021-2026)
9.4.1 North America Gabapentin Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Gabapentin Production, Revenue Forecast (2021-2026)
9.4.3 Europe Gabapentin Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Gabapentin Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Gabapentin Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Gabapentin Production, Revenue Forecast (2021-2026)
9.4.7 Africa Gabapentin Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Gabapentin Production, Revenue Forecast (2021-2026)
9.4.9 South America Gabapentin Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Gabapentin Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Gabapentin by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Gabapentin by Country
10.2 East Asia Market Forecasted Consumption of Gabapentin by Country
10.3 Europe Market Forecasted Consumption of Gabapentin by Countriy
10.4 South Asia Forecasted Consumption of Gabapentin by Country
10.5 Southeast Asia Forecasted Consumption of Gabapentin by Country
10.6 Middle East Forecasted Consumption of Gabapentin by Country
10.7 Africa Forecasted Consumption of Gabapentin by Country
10.8 Oceania Forecasted Consumption of Gabapentin by Country
10.9 South America Forecasted Consumption of Gabapentin by Country
10.10 Rest of the world Forecasted Consumption of Gabapentin by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Gabapentin Distributors List
11.3 Gabapentin Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Gabapentin Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gabapentin Revenue
1.4 Market Analysis by Type
1.4.1 Global Gabapentin Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Capsule
1.4.3 Tablet
1.5 Market by Application
1.5.1 Global Gabapentin Market Share by Application: 2021-2026
1.5.2 Epilepsy
1.5.3 Neuropathic Pain
1.5.4 Restless Legs Syndrome
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gabapentin Market Perspective (2021-2026)
2.2 Gabapentin Growth Trends by Regions
2.2.1 Gabapentin Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Gabapentin Historic Market Size by Regions (2015-2020)
2.2.3 Gabapentin Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Gabapentin Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Gabapentin Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Gabapentin Average Price by Manufacturers (2015-2020)
4 GABAPENTIN PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Gabapentin Market Size (2015-2026)
4.1.2 Gabapentin Key Players in North America (2015-2020)
4.1.3 North America Gabapentin Market Size by Type (2015-2020)
4.1.4 North America Gabapentin Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Gabapentin Market Size (2015-2026)
4.2.2 Gabapentin Key Players in East Asia (2015-2020)
4.2.3 East Asia Gabapentin Market Size by Type (2015-2020)
4.2.4 East Asia Gabapentin Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Gabapentin Market Size (2015-2026)
4.3.2 Gabapentin Key Players in Europe (2015-2020)
4.3.3 Europe Gabapentin Market Size by Type (2015-2020)
4.3.4 Europe Gabapentin Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Gabapentin Market Size (2015-2026)
4.4.2 Gabapentin Key Players in South Asia (2015-2020)
4.4.3 South Asia Gabapentin Market Size by Type (2015-2020)
4.4.4 South Asia Gabapentin Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Gabapentin Market Size (2015-2026)
4.5.2 Gabapentin Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Gabapentin Market Size by Type (2015-2020)
4.5.4 Southeast Asia Gabapentin Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Gabapentin Market Size (2015-2026)
4.6.2 Gabapentin Key Players in Middle East (2015-2020)
4.6.3 Middle East Gabapentin Market Size by Type (2015-2020)
4.6.4 Middle East Gabapentin Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Gabapentin Market Size (2015-2026)
4.7.2 Gabapentin Key Players in Africa (2015-2020)
4.7.3 Africa Gabapentin Market Size by Type (2015-2020)
4.7.4 Africa Gabapentin Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Gabapentin Market Size (2015-2026)
4.8.2 Gabapentin Key Players in Oceania (2015-2020)
4.8.3 Oceania Gabapentin Market Size by Type (2015-2020)
4.8.4 Oceania Gabapentin Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Gabapentin Market Size (2015-2026)
4.9.2 Gabapentin Key Players in South America (2015-2020)
4.9.3 South America Gabapentin Market Size by Type (2015-2020)
4.9.4 South America Gabapentin Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Gabapentin Market Size (2015-2026)
4.10.2 Gabapentin Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Gabapentin Market Size by Type (2015-2020)
4.10.4 Rest of the World Gabapentin Market Size by Application (2015-2020)
5 GABAPENTIN CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Gabapentin Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Gabapentin Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Gabapentin Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Gabapentin Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Gabapentin Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Gabapentin Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Gabapentin Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Gabapentin Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Gabapentin Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Gabapentin Consumption by Countries
5.10.2 Kazakhstan
6 GABAPENTIN SALES MARKET BY TYPE (2015-2026)
6.1 Global Gabapentin Historic Market Size by Type (2015-2020)
6.2 Global Gabapentin Forecasted Market Size by Type (2021-2026)
7 GABAPENTIN CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Gabapentin Historic Market Size by Application (2015-2020)
7.2 Global Gabapentin Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN GABAPENTIN BUSINESS
8.1 Pfizer
8.1.1 Pfizer Company Profile
8.1.2 Pfizer Gabapentin Product Specification
8.1.3 Pfizer Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Sun Pharmaceutical
8.2.1 Sun Pharmaceutical Company Profile
8.2.2 Sun Pharmaceutical Gabapentin Product Specification
8.2.3 Sun Pharmaceutical Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Mylan
8.3.1 Mylan Company Profile
8.3.2 Mylan Gabapentin Product Specification
8.3.3 Mylan Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Assertio Therapeutics
8.4.1 Assertio Therapeutics Company Profile
8.4.2 Assertio Therapeutics Gabapentin Product Specification
8.4.3 Assertio Therapeutics Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Apotex
8.5.1 Apotex Company Profile
8.5.2 Apotex Gabapentin Product Specification
8.5.3 Apotex Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 TEVA
8.6.1 TEVA Company Profile
8.6.2 TEVA Gabapentin Product Specification
8.6.3 TEVA Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Intas
8.7.1 Intas Company Profile
8.7.2 Intas Gabapentin Product Specification
8.7.3 Intas Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Novartis
8.8.1 Novartis Company Profile
8.8.2 Novartis Gabapentin Product Specification
8.8.3 Novartis Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Arbor Pharma
8.9.1 Arbor Pharma Company Profile
8.9.2 Arbor Pharma Gabapentin Product Specification
8.9.3 Arbor Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Aurobindo Pharma
8.10.1 Aurobindo Pharma Company Profile
8.10.2 Aurobindo Pharma Gabapentin Product Specification
8.10.3 Aurobindo Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Jiangsu Enhua
8.11.1 Jiangsu Enhua Company Profile
8.11.2 Jiangsu Enhua Gabapentin Product Specification
8.11.3 Jiangsu Enhua Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Amneal
8.12.1 Amneal Company Profile
8.12.2 Amneal Gabapentin Product Specification
8.12.3 Amneal Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Jiangsu Hengrui
8.13.1 Jiangsu Hengrui Company Profile
8.13.2 Jiangsu Hengrui Gabapentin Product Specification
8.13.3 Jiangsu Hengrui Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Alkem
8.14.1 Alkem Company Profile
8.14.2 Alkem Gabapentin Product Specification
8.14.3 Alkem Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 Marksans Pharma
8.15.1 Marksans Pharma Company Profile
8.15.2 Marksans Pharma Gabapentin Product Specification
8.15.3 Marksans Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.16 Sailike
8.16.1 Sailike Company Profile
8.16.2 Sailike Gabapentin Product Specification
8.16.3 Sailike Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.17 Glenmark
8.17.1 Glenmark Company Profile
8.17.2 Glenmark Gabapentin Product Specification
8.17.3 Glenmark Gabapentin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Gabapentin (2021-2026)
9.2 Global Forecasted Revenue of Gabapentin (2021-2026)
9.3 Global Forecasted Price of Gabapentin (2015-2026)
9.4 Global Forecasted Production of Gabapentin by Region (2021-2026)
9.4.1 North America Gabapentin Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Gabapentin Production, Revenue Forecast (2021-2026)
9.4.3 Europe Gabapentin Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Gabapentin Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Gabapentin Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Gabapentin Production, Revenue Forecast (2021-2026)
9.4.7 Africa Gabapentin Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Gabapentin Production, Revenue Forecast (2021-2026)
9.4.9 South America Gabapentin Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Gabapentin Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Gabapentin by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Gabapentin by Country
10.2 East Asia Market Forecasted Consumption of Gabapentin by Country
10.3 Europe Market Forecasted Consumption of Gabapentin by Countriy
10.4 South Asia Forecasted Consumption of Gabapentin by Country
10.5 Southeast Asia Forecasted Consumption of Gabapentin by Country
10.6 Middle East Forecasted Consumption of Gabapentin by Country
10.7 Africa Forecasted Consumption of Gabapentin by Country
10.8 Oceania Forecasted Consumption of Gabapentin by Country
10.9 South America Forecasted Consumption of Gabapentin by Country
10.10 Rest of the world Forecasted Consumption of Gabapentin by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Gabapentin Distributors List
11.3 Gabapentin Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Gabapentin Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Gabapentin Market Share by Type: 2020 VS 2026
Table 2. Capsule Features
Table 3. Tablet Features
Table 11. Global Gabapentin Market Share by Application: 2020 VS 2026
Table 12. Epilepsy Case Studies
Table 13. Neuropathic Pain Case Studies
Table 14. Restless Legs Syndrome Case Studies
Table 15. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Gabapentin Report Years Considered
Table 29. Global Gabapentin Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Gabapentin Market Share by Regions: 2021 VS 2026
Table 31. North America Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Gabapentin Consumption by Countries (2015-2020)
Table 42. East Asia Gabapentin Consumption by Countries (2015-2020)
Table 43. Europe Gabapentin Consumption by Region (2015-2020)
Table 44. South Asia Gabapentin Consumption by Countries (2015-2020)
Table 45. Southeast Asia Gabapentin Consumption by Countries (2015-2020)
Table 46. Middle East Gabapentin Consumption by Countries (2015-2020)
Table 47. Africa Gabapentin Consumption by Countries (2015-2020)
Table 48. Oceania Gabapentin Consumption by Countries (2015-2020)
Table 49. South America Gabapentin Consumption by Countries (2015-2020)
Table 50. Rest of the World Gabapentin Consumption by Countries (2015-2020)
Table 51. Pfizer Gabapentin Product Specification
Table 52. Sun Pharmaceutical Gabapentin Product Specification
Table 53. Mylan Gabapentin Product Specification
Table 54. Assertio Therapeutics Gabapentin Product Specification
Table 55. Apotex Gabapentin Product Specification
Table 56. TEVA Gabapentin Product Specification
Table 57. Intas Gabapentin Product Specification
Table 58. Novartis Gabapentin Product Specification
Table 59. Arbor Pharma Gabapentin Product Specification
Table 60. Aurobindo Pharma Gabapentin Product Specification
Table 61. Jiangsu Enhua Gabapentin Product Specification
Table 62. Amneal Gabapentin Product Specification
Table 63. Jiangsu Hengrui Gabapentin Product Specification
Table 64. Alkem Gabapentin Product Specification
Table 65. Marksans Pharma Gabapentin Product Specification
Table 66. Sailike Gabapentin Product Specification
Table 67. Glenmark Gabapentin Product Specification
Table 101. Global Gabapentin Production Forecast by Region (2021-2026)
Table 102. Global Gabapentin Sales Volume Forecast by Type (2021-2026)
Table 103. Global Gabapentin Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Gabapentin Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Gabapentin Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Gabapentin Sales Price Forecast by Type (2021-2026)
Table 107. Global Gabapentin Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Gabapentin Consumption Value Forecast by Application (2021-2026)
Table 109. North America Gabapentin Consumption Forecast 2021-2026 by Country
Table 110. East Asia Gabapentin Consumption Forecast 2021-2026 by Country
Table 111. Europe Gabapentin Consumption Forecast 2021-2026 by Country
Table 112. South Asia Gabapentin Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Gabapentin Consumption Forecast 2021-2026 by Country
Table 114. Middle East Gabapentin Consumption Forecast 2021-2026 by Country
Table 115. Africa Gabapentin Consumption Forecast 2021-2026 by Country
Table 116. Oceania Gabapentin Consumption Forecast 2021-2026 by Country
Table 117. South America Gabapentin Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Gabapentin Consumption Forecast 2021-2026 by Country
Table 119. Gabapentin Distributors List
Table 120. Gabapentin Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Gabapentin Consumption and Growth Rate (2015-2020)
Figure 2. North America Gabapentin Consumption Market Share by Countries in 2020
Figure 3. United States Gabapentin Consumption and Growth Rate (2015-2020)
Figure 4. Canada Gabapentin Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Gabapentin Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Gabapentin Consumption Market Share by Countries in 2020
Figure 8. China Gabapentin Consumption and Growth Rate (2015-2020)
Figure 9. Japan Gabapentin Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Gabapentin Consumption and Growth Rate (2015-2020)
Figure 11. Europe Gabapentin Consumption and Growth Rate
Figure 12. Europe Gabapentin Consumption Market Share by Region in 2020
Figure 13. Germany Gabapentin Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Gabapentin Consumption and Growth Rate (2015-2020)
Figure 15. France Gabapentin Consumption and Growth Rate (2015-2020)
Figure 16. Italy Gabapentin Consumption and Growth Rate (2015-2020)
Figure 17. Russia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 18. Spain Gabapentin Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Gabapentin Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Gabapentin Consumption and Growth Rate (2015-2020)
Figure 21. Poland Gabapentin Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Gabapentin Consumption and Growth Rate
Figure 23. South Asia Gabapentin Consumption Market Share by Countries in 2020
Figure 24. India Gabapentin Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Gabapentin Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Gabapentin Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Gabapentin Consumption and Growth Rate
Figure 28. Southeast Asia Gabapentin Consumption Market Share by Countries in 2020
Figure 29. Indonesia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Gabapentin Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Gabapentin Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Gabapentin Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Gabapentin Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Gabapentin Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Gabapentin Consumption and Growth Rate
Figure 37. Middle East Gabapentin Consumption Market Share by Countries in 2020
Figure 38. Turkey Gabapentin Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 40. Iran Gabapentin Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Gabapentin Consumption and Growth Rate (2015-2020)
Figure 42. Israel Gabapentin Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Gabapentin Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Gabapentin Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Gabapentin Consumption and Growth Rate (2015-2020)
Figure 46. Oman Gabapentin Consumption and Growth Rate (2015-2020)
Figure 47. Africa Gabapentin Consumption and Growth Rate
Figure 48. Africa Gabapentin Consumption Market Share by Countries in 2020
Figure 49. Nigeria Gabapentin Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Gabapentin Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Gabapentin Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Gabapentin Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Gabapentin Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Gabapentin Consumption and Growth Rate
Figure 55. Oceania Gabapentin Consumption Market Share by Countries in 2020
Figure 56. Australia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Gabapentin Consumption and Growth Rate (2015-2020)
Figure 58. South America Gabapentin Consumption and Growth Rate
Figure 59. South America Gabapentin Consumption Market Share by Countries in 2020
Figure 60. Brazil Gabapentin Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Gabapentin Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 63. Chile Gabapentin Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Gabapentin Consumption and Growth Rate (2015-2020)
Figure 65. Peru Gabapentin Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Gabapentin Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Gabapentin Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Gabapentin Consumption and Growth Rate
Figure 69. Rest of the World Gabapentin Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Gabapentin Consumption and Growth Rate (2015-2020)
Figure 71. Global Gabapentin Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Gabapentin Price and Trend Forecast (2015-2026)
Figure 74. North America Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 75. North America Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 91. South America Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Gabapentin Consumption Forecast 2021-2026
Figure 95. East Asia Gabapentin Consumption Forecast 2021-2026
Figure 96. Europe Gabapentin Consumption Forecast 2021-2026
Figure 97. South Asia Gabapentin Consumption Forecast 2021-2026
Figure 98. Southeast Asia Gabapentin Consumption Forecast 2021-2026
Figure 99. Middle East Gabapentin Consumption Forecast 2021-2026
Figure 100. Africa Gabapentin Consumption Forecast 2021-2026
Figure 101. Oceania Gabapentin Consumption Forecast 2021-2026
Figure 102. South America Gabapentin Consumption Forecast 2021-2026
Figure 103. Rest of the world Gabapentin Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Gabapentin Market Share by Type: 2020 VS 2026
Table 2. Capsule Features
Table 3. Tablet Features
Table 11. Global Gabapentin Market Share by Application: 2020 VS 2026
Table 12. Epilepsy Case Studies
Table 13. Neuropathic Pain Case Studies
Table 14. Restless Legs Syndrome Case Studies
Table 15. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Gabapentin Report Years Considered
Table 29. Global Gabapentin Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Gabapentin Market Share by Regions: 2021 VS 2026
Table 31. North America Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Gabapentin Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Gabapentin Consumption by Countries (2015-2020)
Table 42. East Asia Gabapentin Consumption by Countries (2015-2020)
Table 43. Europe Gabapentin Consumption by Region (2015-2020)
Table 44. South Asia Gabapentin Consumption by Countries (2015-2020)
Table 45. Southeast Asia Gabapentin Consumption by Countries (2015-2020)
Table 46. Middle East Gabapentin Consumption by Countries (2015-2020)
Table 47. Africa Gabapentin Consumption by Countries (2015-2020)
Table 48. Oceania Gabapentin Consumption by Countries (2015-2020)
Table 49. South America Gabapentin Consumption by Countries (2015-2020)
Table 50. Rest of the World Gabapentin Consumption by Countries (2015-2020)
Table 51. Pfizer Gabapentin Product Specification
Table 52. Sun Pharmaceutical Gabapentin Product Specification
Table 53. Mylan Gabapentin Product Specification
Table 54. Assertio Therapeutics Gabapentin Product Specification
Table 55. Apotex Gabapentin Product Specification
Table 56. TEVA Gabapentin Product Specification
Table 57. Intas Gabapentin Product Specification
Table 58. Novartis Gabapentin Product Specification
Table 59. Arbor Pharma Gabapentin Product Specification
Table 60. Aurobindo Pharma Gabapentin Product Specification
Table 61. Jiangsu Enhua Gabapentin Product Specification
Table 62. Amneal Gabapentin Product Specification
Table 63. Jiangsu Hengrui Gabapentin Product Specification
Table 64. Alkem Gabapentin Product Specification
Table 65. Marksans Pharma Gabapentin Product Specification
Table 66. Sailike Gabapentin Product Specification
Table 67. Glenmark Gabapentin Product Specification
Table 101. Global Gabapentin Production Forecast by Region (2021-2026)
Table 102. Global Gabapentin Sales Volume Forecast by Type (2021-2026)
Table 103. Global Gabapentin Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Gabapentin Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Gabapentin Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Gabapentin Sales Price Forecast by Type (2021-2026)
Table 107. Global Gabapentin Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Gabapentin Consumption Value Forecast by Application (2021-2026)
Table 109. North America Gabapentin Consumption Forecast 2021-2026 by Country
Table 110. East Asia Gabapentin Consumption Forecast 2021-2026 by Country
Table 111. Europe Gabapentin Consumption Forecast 2021-2026 by Country
Table 112. South Asia Gabapentin Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Gabapentin Consumption Forecast 2021-2026 by Country
Table 114. Middle East Gabapentin Consumption Forecast 2021-2026 by Country
Table 115. Africa Gabapentin Consumption Forecast 2021-2026 by Country
Table 116. Oceania Gabapentin Consumption Forecast 2021-2026 by Country
Table 117. South America Gabapentin Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Gabapentin Consumption Forecast 2021-2026 by Country
Table 119. Gabapentin Distributors List
Table 120. Gabapentin Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Gabapentin Consumption and Growth Rate (2015-2020)
Figure 2. North America Gabapentin Consumption Market Share by Countries in 2020
Figure 3. United States Gabapentin Consumption and Growth Rate (2015-2020)
Figure 4. Canada Gabapentin Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Gabapentin Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Gabapentin Consumption Market Share by Countries in 2020
Figure 8. China Gabapentin Consumption and Growth Rate (2015-2020)
Figure 9. Japan Gabapentin Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Gabapentin Consumption and Growth Rate (2015-2020)
Figure 11. Europe Gabapentin Consumption and Growth Rate
Figure 12. Europe Gabapentin Consumption Market Share by Region in 2020
Figure 13. Germany Gabapentin Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Gabapentin Consumption and Growth Rate (2015-2020)
Figure 15. France Gabapentin Consumption and Growth Rate (2015-2020)
Figure 16. Italy Gabapentin Consumption and Growth Rate (2015-2020)
Figure 17. Russia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 18. Spain Gabapentin Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Gabapentin Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Gabapentin Consumption and Growth Rate (2015-2020)
Figure 21. Poland Gabapentin Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Gabapentin Consumption and Growth Rate
Figure 23. South Asia Gabapentin Consumption Market Share by Countries in 2020
Figure 24. India Gabapentin Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Gabapentin Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Gabapentin Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Gabapentin Consumption and Growth Rate
Figure 28. Southeast Asia Gabapentin Consumption Market Share by Countries in 2020
Figure 29. Indonesia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Gabapentin Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Gabapentin Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Gabapentin Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Gabapentin Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Gabapentin Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Gabapentin Consumption and Growth Rate
Figure 37. Middle East Gabapentin Consumption Market Share by Countries in 2020
Figure 38. Turkey Gabapentin Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 40. Iran Gabapentin Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Gabapentin Consumption and Growth Rate (2015-2020)
Figure 42. Israel Gabapentin Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Gabapentin Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Gabapentin Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Gabapentin Consumption and Growth Rate (2015-2020)
Figure 46. Oman Gabapentin Consumption and Growth Rate (2015-2020)
Figure 47. Africa Gabapentin Consumption and Growth Rate
Figure 48. Africa Gabapentin Consumption Market Share by Countries in 2020
Figure 49. Nigeria Gabapentin Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Gabapentin Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Gabapentin Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Gabapentin Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Gabapentin Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Gabapentin Consumption and Growth Rate
Figure 55. Oceania Gabapentin Consumption Market Share by Countries in 2020
Figure 56. Australia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Gabapentin Consumption and Growth Rate (2015-2020)
Figure 58. South America Gabapentin Consumption and Growth Rate
Figure 59. South America Gabapentin Consumption Market Share by Countries in 2020
Figure 60. Brazil Gabapentin Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Gabapentin Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Gabapentin Consumption and Growth Rate (2015-2020)
Figure 63. Chile Gabapentin Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Gabapentin Consumption and Growth Rate (2015-2020)
Figure 65. Peru Gabapentin Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Gabapentin Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Gabapentin Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Gabapentin Consumption and Growth Rate
Figure 69. Rest of the World Gabapentin Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Gabapentin Consumption and Growth Rate (2015-2020)
Figure 71. Global Gabapentin Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Gabapentin Price and Trend Forecast (2015-2026)
Figure 74. North America Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 75. North America Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 91. South America Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Gabapentin Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Gabapentin Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Gabapentin Consumption Forecast 2021-2026
Figure 95. East Asia Gabapentin Consumption Forecast 2021-2026
Figure 96. Europe Gabapentin Consumption Forecast 2021-2026
Figure 97. South Asia Gabapentin Consumption Forecast 2021-2026
Figure 98. Southeast Asia Gabapentin Consumption Forecast 2021-2026
Figure 99. Middle East Gabapentin Consumption Forecast 2021-2026
Figure 100. Africa Gabapentin Consumption Forecast 2021-2026
Figure 101. Oceania Gabapentin Consumption Forecast 2021-2026
Figure 102. South America Gabapentin Consumption Forecast 2021-2026
Figure 103. Rest of the world Gabapentin Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
